Results from a prospective clinical trial showed that a blood test looking at specific biomarkers was able to detect recurrences of lung cancer an average of six months before conventional imaging ...

Lung cancer remains the leading cause of cancer deaths in Virginia, according to a new report from the American Lung Association. The 2025 “State of Lung Cancer” report for Virginia found in most ...

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces challenges in uptake and education. Multistakeholder partnerships and ...

Robert Kratzke, MD, urged insurance providers to prioritize fast biomarker testing in non–small cell lung cancer, saying it’s both cost-effective and life-saving. Delays in molecular testing for ...

Dr. Joshua K. Sabari sat down with Terri Conneran at the 2025 World Conference on Lung Cancer for a conversation on the importance of biomarker testing. Dr. Joshua K. Sabari, a thoracic medical ...

A recent survey found 62% of pulmonologists said they order biomarker testing for non-small cell lung cancer patients. Among those who said they do not order such testing, 84% said the reason is they ...

When comprehensive tissue next-generation sequencing (NGS) fails, liquid biopsy should be the reflex strategy, especially in ...

Lung cancer in never-smokers challenges lifestyle-based assumptions and underscores the need to address stigma that can delay evaluation and psychosocial support. Subtle, prolonged respiratory or ...

“It's My Wish, We Need This Program”: Qualitative Reflections From People With High-Grade Brain Cancer Consenting to Postmortem Brain Donation Targeted therapy has transformed treatment of non–small ...

NASHVILLE, Tenn. (WSMV) - A bill requiring state-run insurance plans to pay for biomarker testing passed committee in an 8-1 vote today at the Tennessee Capitol, moving one step closer to becoming law ...